Literature DB >> 21639839

Kinetics of chaperone activity of proteins Hsp70 and Hdj1 in human leukemia u-937 cells after preconditioning with thermal shock or compound u-133.

V F Lazarev1, K V Onokhin, O I Antimonova, S G Polonik, I V Guzhova, B A Margulis.   

Abstract

Kinetics of the chaperone activity of proteins Hsp70 and Hdj1 were analyzed in human U-937 promonocytes during their response to heat shock or to treatment with the echinochrome triacetyl glucoside derivative U-133. To measure the chaperone activity of both proteins, a special test was developed for their recognition and binding of a denatured protein. Using this test, the chaperone activity could be concurrently estimated in large numbers of cellular or tissue extracts. We also estimated the contents of both chaperones in cells by immunoblotting. The values for contents of Hsp70 and Hdj1 obtained by two independent test systems coincided, and this suggested that the substrate-binding activity could change proportionally to the chaperone content in the protein mixture. Therefore, the test developed by us can be employed for high throughput screening of drugs activating cellular chaperones. The analysis of quantity and activity of two cellular chaperones during the cell response to heat stress or to the drug-like substance U-133 showed that both factors caused the accumulation of chaperones with similar kinetics. We conclude that the efficiency of drug preconditioning could be close to the efficiency of hyperthermia and that the high activity of chaperones could be retained in human cells for no less than 1.5 days.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21639839     DOI: 10.1134/S0006297911050099

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  7 in total

1.  Hsp70 chaperone-based gel composition as a novel immunotherapeutic anti-tumor tool.

Authors:  Sergey V Abkin; Katerina M Pankratova; Elena Yu Komarova; Irina V Guzhova; Boris A Margulis
Journal:  Cell Stress Chaperones       Date:  2012-12-12       Impact factor: 3.667

2.  Tumor targeting using magnetic nanoparticle Hsp70 conjugate in a model of C6 glioma.

Authors:  Maxim A Shevtsov; Ludmila Y Yakovleva; Boris P Nikolaev; Yaroslav Y Marchenko; Anatolii V Dobrodumov; Kirill V Onokhin; Yana S Onokhina; Sergey A Selkov; Anastasiia L Mikhrina; Irina V Guzhova; Marina G Martynova; Olga A Bystrova; Alexander M Ischenko; Boris A Margulis
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

3.  The development of modified human Hsp70 (HSPA1A) and its production in the milk of transgenic mice.

Authors:  Yaroslav G Gurskiy; David G Garbuz; Nataliya V Soshnikova; Aleksey N Krasnov; Alexei Deikin; Vladimir F Lazarev; Dmitry Sverchinskyi; Boris A Margulis; Olga G Zatsepina; Vadim L Karpov; Svetlana N Belzhelarskaya; Evgenia Feoktistova; Sofia G Georgieva; Michael B Evgen'ev
Journal:  Cell Stress Chaperones       Date:  2016-08-10       Impact factor: 3.667

4.  Prevention of High Glucose-Mediated EMT by Inhibition of Hsp70 Chaperone.

Authors:  Alina D Nikotina; Snezhana A Vladimirova; Elena Y Komarova; Dmitry Alexeev; Sergey Efremov; Elizaveta Leonova; Rostislav Pavlov; Viktor G Kartsev; Sergey G Polonik; Boris A Margulis; Irina V Guzhova
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

5.  Pyrrolylquinoxaline-2-One Derivative as a Potent Therapeutic Factor for Brain Trauma Rehabilitation.

Authors:  Elizaveta A Dutysheva; Marina A Mikeladze; Maria A Trestsova; Nikolay D Aksenov; Irina A Utepova; Elena R Mikhaylova; Roman V Suezov; Valery N Charushin; Oleg N Chupakhin; Irina V Guzhova; Boris A Margulis; Vladimir F Lazarev
Journal:  Pharmaceutics       Date:  2020-04-30       Impact factor: 6.321

6.  Disruption of the Complex between GAPDH and Hsp70 Sensitizes C6 Glioblastoma Cells to Hypoxic Stress.

Authors:  Marina A Mikeladze; Elizaveta A Dutysheva; Victor G Kartsev; Boris A Margulis; Irina V Guzhova; Vladimir F Lazarev
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

7.  Sensitizing tumor cells to conventional drugs: HSP70 chaperone inhibitors, their selection and application in cancer models.

Authors:  Vladimir F Lazarev; Dmitry V Sverchinsky; Elena R Mikhaylova; Pavel I Semenyuk; Elena Y Komarova; Sergey A Niskanen; Alina D Nikotina; Anton V Burakov; Viktor G Kartsev; Irina V Guzhova; Boris A Margulis
Journal:  Cell Death Dis       Date:  2018-01-18       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.